Company Filing History:
Years Active: 2010-2017
Title: John M D'Auria: Innovator in Radioisotope Isolation
Introduction
John M D'Auria is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of radioisotope isolation, holding a total of 3 patents. His work focuses on methods that enhance the production of diagnostic and therapeutic radiopharmaceuticals.
Latest Patents
One of his latest patents is titled "Method and apparatus for isolating the radioisotope molybdenum-99." This innovative method involves vaporizing a source compound containing molybdenum and ionizing it to form ions. The ions are then separated to isolate those containing molybdenum, which can be collected for further use. This process results in molybdenum with a relatively high specific radioactivity, which is essential for producing the diagnostic radioisotope technetium-99m through radioactive decay.
Another significant patent by D'Auria is "Method and apparatus for isolating a radioisotope." This method also involves vaporizing a source compound containing isotopes of an element. The vaporized compound is ionized to create charged particles, which are then separated to isolate the second isotope. This isolated isotope can be utilized to produce radiopharmaceuticals with enhanced specific activity, improving their therapeutic and diagnostic properties.
Career Highlights
John M D'Auria is currently associated with Advanced Applied Physics Solutions, Inc. His work at this company has been pivotal in advancing the field of radioisotope applications in medicine. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
D'Auria has collaborated with notable professionals in his field, including Suzanne Lapi and Thomas J Ruth. These collaborations have further enriched his research and development efforts in radioisotope isolation.
Conclusion
John M D'Auria is a distinguished inventor whose work in radioisotope isolation has significant implications for medical diagnostics and treatment. His innovative patents and collaborations highlight his commitment to advancing this critical field.